Review for Final Exam
The final exam will consist of questions in the multiple-choice and true/false format.
A scantron will be provided for the final exam.
Focus on the lectures (i.e. notes and
PowerPoint slides) and readings, particularly the posted articles.
Modes of HIV transmission & Prevention of HIV/AIDS
-
How have the trends in misconception about HIV/AIDS changed over time?
-
Three reasons why HAART is not the ultimate panacea for HIV/AIDS
-
Three examples of how antiretroviral therapy benefits prevention
-
How have HIV infection rates in the U.S. changed in the last 25 years?
o
What can we attribute the decline in infection in the mid-to-late 1980s?
o
Refer to slide Current Challenge in the U.S.; know three potential reasons
for the recent increase in infection rates among MSM.
-
From the 1980s to1990s, what group was targeted for prevention efforts? Why?
-
Positive prevention is endorsed by whom?
It is consistent with ?
o
Know the recommendations for Africa outlined in both the required
reading and slides.
-
Know the sources of infectious HIV
o
HIV is present in which cells?
o
Why can HIV be readily transmitted via some bodily fluids (e.g. blood),
but not others (e.g. perspiration) ?
o
High concentrations of HIV are found in which four bodily fluids?
o
Is HIV fragile outside of its host?
-
From an epidemiologic perspective, why do family members of HIV+
hemophiliacs offer a unique opportunity to study casual transmission of HIV?
-
Three modes of HIV transmission
:
1) Identify the three forms of
Blood-to-blood transmission
;
o
What can be done to prevent these routes of transmission ?
-
2)
Sexual transmission
o
Why is intercourse (vaginal/anal) a good mode of transmission?
o
What is the approximate risk of male to female transmission of HIV?
Reasons why one gender is more susceptible to HIV than the other
o
Review slide on oral-genital transmission of HIV
o
Be familiar with the ABC campaign
What do the three letters represent?
This
preview
has intentionally blurred sections.
Sign up to view the full version.

This is the end of the preview.
Sign up
to
access the rest of the document.
- Fall '11
- staff
- Antiretroviral drug
-
Click to edit the document details